BASTIDE LE CONFORT MEDICAL (BLC.PA) Stock Fundamental Analysis
Europe - EPA:BLC - FR0000035370 - Common Stock
25.7 EUR
-0.15 (-0.58%)
BLC gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 27 industry peers in the Health Care Providers & Services industry. While BLC is still in line with the averages on profitability rating, there are concerns on its financial health. BLC has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year BLC was profitable.
In the past year BLC had a positive cash flow from operations.
Of the past 5 years BLC 4 years were profitable.
In the past 5 years BLC always reported a positive cash flow from operatings.
1.2 Ratios
BLC's Return On Assets of 0.25% is on the low side compared to the rest of the industry. BLC is outperformed by 77.78% of its industry peers.
Looking at the Return On Equity, with a value of 2.25%, BLC is doing worse than 74.07% of the companies in the same industry.
With a decent Return On Invested Capital value of 5.65%, BLC is doing good in the industry, outperforming 62.96% of the companies in the same industry.
BLC had an Average Return On Invested Capital over the past 3 years of 5.34%. This is in line with the industry average of 6.10%.
The 3 year average ROIC (5.34%) for BLC is below the current ROIC(5.65%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.25% | ||
| ROE | 2.25% | ||
| ROIC | 5.65% |
ROA(3y)1.29%
ROA(5y)1.7%
ROE(3y)9.6%
ROE(5y)12.13%
ROIC(3y)5.34%
ROIC(5y)5.17%
1.3 Margins
BLC has a Profit Margin of 0.32%. This is in the lower half of the industry: BLC underperforms 74.07% of its industry peers.
With a Operating Margin value of 7.67%, BLC perfoms like the industry average, outperforming 59.26% of the companies in the same industry.
BLC's Operating Margin has improved in the last couple of years.
BLC has a better Gross Margin (67.54%) than 74.07% of its industry peers.
In the last couple of years the Gross Margin of BLC has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.67% | ||
| PM (TTM) | 0.32% | ||
| GM | 67.54% |
OM growth 3Y3.59%
OM growth 5Y6.18%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.18%
GM growth 5Y6.9%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), BLC is creating some value.
Compared to 1 year ago, BLC has less shares outstanding
The number of shares outstanding for BLC has been increased compared to 5 years ago.
BLC has a better debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 1.39, we must say that BLC is in the distress zone and has some risk of bankruptcy.
BLC has a worse Altman-Z score (1.39) than 62.96% of its industry peers.
The Debt to FCF ratio of BLC is 9.33, which is on the high side as it means it would take BLC, 9.33 years of fcf income to pay off all of its debts.
BLC has a Debt to FCF ratio (9.33) which is comparable to the rest of the industry.
BLC has a Debt/Equity ratio of 5.20. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 5.20, BLC is not doing good in the industry: 88.89% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.2 | ||
| Debt/FCF | 9.33 | ||
| Altman-Z | 1.39 |
ROIC/WACC1.2
WACC4.72%
2.3 Liquidity
A Current Ratio of 1.19 indicates that BLC should not have too much problems paying its short term obligations.
The Current ratio of BLC (1.19) is comparable to the rest of the industry.
A Quick Ratio of 0.96 indicates that BLC may have some problems paying its short term obligations.
BLC has a Quick ratio of 0.96. This is comparable to the rest of the industry: BLC outperforms 51.85% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.19 | ||
| Quick Ratio | 0.96 |
3. Growth
3.1 Past
The earnings per share for BLC have decreased strongly by -71.43% in the last year.
Looking at the last year, BLC shows a small growth in Revenue. The Revenue has grown by 3.24% in the last year.
The Revenue has been growing by 9.55% on average over the past years. This is quite good.
EPS 1Y (TTM)-71.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%130.77%
Revenue 1Y (TTM)3.24%
Revenue growth 3Y6.06%
Revenue growth 5Y9.55%
Sales Q2Q%3.96%
3.2 Future
BLC is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.08% yearly.
The Revenue is expected to grow by 5.06% on average over the next years.
EPS Next Y-4.84%
EPS Next 2Y7.02%
EPS Next 3Y6.08%
EPS Next 5YN/A
Revenue Next Year-7.71%
Revenue Next 2Y-3.05%
Revenue Next 3Y-0.19%
Revenue Next 5Y5.06%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 116.82 indicates a quite expensive valuation of BLC.
Based on the Price/Earnings ratio, BLC is valued a bit more expensive than the industry average as 77.78% of the companies are valued more cheaply.
BLC's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.30.
Based on the Price/Forward Earnings ratio of 8.61, the valuation of BLC can be described as reasonable.
Based on the Price/Forward Earnings ratio, BLC is valued cheaply inside the industry as 96.30% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.73, BLC is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 116.82 | ||
| Fwd PE | 8.61 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BLC indicates a rather cheap valuation: BLC is cheaper than 85.19% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, BLC is valued cheaply inside the industry as 81.48% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.2 | ||
| EV/EBITDA | 5.74 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.02%
EPS Next 3Y6.08%
5. Dividend
5.1 Amount
BLC does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
EPA:BLC (9/12/2025, 7:00:00 PM)
25.7
-0.15 (-0.58%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners9.28%
Inst Owner ChangeN/A
Ins Owners1.58%
Ins Owner ChangeN/A
Market Cap189.41M
Analysts83.33
Price Target36.72 (42.88%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0.22
Dividend Growth(5Y)-3.5%
DP42.86%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)9.09%
PT rev (3m)9.09%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-13.25%
EPS NY rev (3m)-13.25%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-12.63%
Revenue NY rev (3m)-13.86%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 116.82 | ||
| Fwd PE | 8.61 | ||
| P/S | 0.35 | ||
| P/FCF | 4.2 | ||
| P/OCF | 1.69 | ||
| P/B | 2.49 | ||
| P/tB | N/A | ||
| EV/EBITDA | 5.74 |
EPS(TTM)0.22
EY0.86%
EPS(NY)2.98
Fwd EY11.61%
FCF(TTM)6.12
FCFY23.81%
OCF(TTM)15.22
OCFY59.2%
SpS73.31
BVpS10.32
TBVpS-19.15
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.25% | ||
| ROE | 2.25% | ||
| ROCE | 8.61% | ||
| ROIC | 5.65% | ||
| ROICexc | 5.65% | ||
| ROICexgc | 10.3% | ||
| OM | 7.67% | ||
| PM (TTM) | 0.32% | ||
| GM | 67.54% | ||
| FCFM | 8.35% |
ROA(3y)1.29%
ROA(5y)1.7%
ROE(3y)9.6%
ROE(5y)12.13%
ROIC(3y)5.34%
ROIC(5y)5.17%
ROICexc(3y)5.7%
ROICexc(5y)5.58%
ROICexgc(3y)12.68%
ROICexgc(5y)11.8%
ROCE(3y)8.16%
ROCE(5y)7.93%
ROICexcg growth 3Y11.16%
ROICexcg growth 5Y1.85%
ROICexc growth 3Y8.09%
ROICexc growth 5Y5.81%
OM growth 3Y3.59%
OM growth 5Y6.18%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.18%
GM growth 5Y6.9%
F-Score6
Asset Turnover0.8
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.2 | ||
| Debt/FCF | 9.33 | ||
| Debt/EBITDA | 3.72 | ||
| Cap/Depr | 103.59% | ||
| Cap/Sales | 12.41% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 105.61% | ||
| Profit Quality | 2640.05% | ||
| Current Ratio | 1.19 | ||
| Quick Ratio | 0.96 | ||
| Altman-Z | 1.39 |
F-Score6
WACC4.72%
ROIC/WACC1.2
Cap/Depr(3y)89.47%
Cap/Depr(5y)88.81%
Cap/Sales(3y)10.8%
Cap/Sales(5y)10.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-71.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%130.77%
EPS Next Y-4.84%
EPS Next 2Y7.02%
EPS Next 3Y6.08%
EPS Next 5YN/A
Revenue 1Y (TTM)3.24%
Revenue growth 3Y6.06%
Revenue growth 5Y9.55%
Sales Q2Q%3.96%
Revenue Next Year-7.71%
Revenue Next 2Y-3.05%
Revenue Next 3Y-0.19%
Revenue Next 5Y5.06%
EBIT growth 1Y3.82%
EBIT growth 3Y9.86%
EBIT growth 5Y16.32%
EBIT Next Year166.67%
EBIT Next 3Y44.23%
EBIT Next 5YN/A
FCF growth 1Y197.72%
FCF growth 3Y10.22%
FCF growth 5Y6.95%
OCF growth 1Y63.86%
OCF growth 3Y7.62%
OCF growth 5Y8.72%